11-111727036-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_181699.3(PPP2R1B):​c.1933G>A​(p.Gly645Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)

Consequence

PPP2R1B
NM_181699.3 missense

Scores

1
3
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.22
Variant links:
Genes affected
PPP2R1B (HGNC:9303): (protein phosphatase 2 scaffold subunit Abeta) This gene encodes a constant regulatory subunit of protein phosphatase 2. Protein phosphatase 2 is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. The constant regulatory subunit A serves as a scaffolding molecule to coordinate the assembly of the catalytic subunit and a variable regulatory B subunit. This gene encodes a beta isoform of the constant regulatory subunit A. Mutations in this gene have been associated with some lung and colon cancers. Alternatively spliced transcript variants have been described. [provided by RefSeq, Apr 2010]
SIK2 (HGNC:21680): (salt inducible kinase 2) Enables ATP binding activity; magnesium ion binding activity; and protein serine/threonine kinase activity. Involved in intracellular signal transduction and protein autophosphorylation. Predicted to be located in nucleus. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SIK2NM_015191.3 linkc.*2907C>T 3_prime_UTR_variant 15/15 ENST00000304987.4 NP_056006.1 Q9H0K1A0A024R3G7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PPP2R1BENST00000311129.9 linkc.1933G>A p.Gly645Arg missense_variant 16/161 ENSP00000311344.5 P30154-2
SIK2ENST00000304987.4 linkc.*2907C>T 3_prime_UTR_variant 15/151 NM_015191.3 ENSP00000305976.3 Q9H0K1
PPP2R1BENST00000530787.1 linkn.65G>A non_coding_transcript_exon_variant 2/21
PPP2R1BENST00000426998.6 linkc.1741G>A p.Gly581Arg missense_variant 14/142 ENSP00000410671.2 P30154-3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 10, 2024The c.1933G>A (p.G645R) alteration is located in exon 16 (coding exon 16) of the PPP2R1B gene. This alteration results from a G to A substitution at nucleotide position 1933, causing the glycine (G) at amino acid position 645 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
9.8
DANN
Uncertain
0.99
Eigen
Benign
-0.37
Eigen_PC
Benign
-0.22
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.60
T;T
M_CAP
Benign
0.0046
T
MetaRNN
Benign
0.20
T;T
MetaSVM
Benign
-1.0
T
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-0.050
N;N
REVEL
Benign
0.056
Sift
Uncertain
0.019
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
0.018
B;.
Vest4
0.38
MutPred
0.18
Gain of MoRF binding (P = 0.0735);.;
MVP
0.59
MPC
0.26
ClinPred
0.98
D
GERP RS
4.5
gMVP
0.18

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.41
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.41
Position offset: 21

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr11-111597760; API